Twice-daily, low-dose pramipexole in ear
β
Karl Kieburtz; The Parkinson Study Group PramiBID Investigators
π
Article
π
2010
π
John Wiley and Sons
π
English
β 137 KB
π 1 views
## Abstract To compare the safety and efficacy of low dosages of pramipexole given twice daily (bid) in early Parkinson's disease (PD) with those of a standard 3 times daily (tid) regimen in a randomized, doubleβblind, placebo controlled trial involving 311 early PD patients not receiving dopaminer